Definitions of response to treatment
| Hematologic response: blood counts |
| Complete (CHR) |
| Platelets <450 × 109/L |
| WBC <10 × 109/L |
| Differential: No immature granulocytes and <5% basophils |
| Cytogenetic response: Ph-positive metaphases |
| Complete: 0% |
| Partial: 1%-35% |
| Minor: 36%-65% |
| Minimal: 66%-95% |
| Molecular response: BCR-ABL transcripts |
| Complete: Transcripts not detectable |
| Major: 0.1% |
| Hematologic response: blood counts |
| Complete (CHR) |
| Platelets <450 × 109/L |
| WBC <10 × 109/L |
| Differential: No immature granulocytes and <5% basophils |
| Cytogenetic response: Ph-positive metaphases |
| Complete: 0% |
| Partial: 1%-35% |
| Minor: 36%-65% |
| Minimal: 66%-95% |
| Molecular response: BCR-ABL transcripts |
| Complete: Transcripts not detectable |
| Major: 0.1% |
The complete cytogenetic response (CCyR) and partial cytogenetic re-sponse (PCyR) rates may be combined and referred to as a major cytogenetic response (MCyR) rate. A major molecular response (MMR) is equivalent to a 3-log reduction from a standardized baseline value of 100%. The terms “transcripts not detected” and “transcripts not detectable” are preferred to “complete molecular response” (sometimes referred to as CMR). There is no current agreement as to whether RQ-PCR technology is as sensitive as nested PCR and thus whether the finding of undetectable transcripts by RQ-PCR needs to be confirmed with nested PCR.